Strep. Groups A, B, C, G
Antibiotic Sensitivities[1]
Organisms | ' | Strep, Group A, B, C, G |
Penicillins | Penicillin G | + |
Penicillin V | + | |
Anti-Staphylocccal Penicillins | Methicillin | + |
Nafcillin/Oxacillin | + | |
Cloxacillin/Diclox. | + | |
Amino-Penicillins | AMP/Amox | + |
Amox/Clav | + | |
AMP-Sulb | + | |
Anti-Pseudomonal Penicillins | Ticarcillin | + |
Ticar-Clav | + | |
Pip-Taxo | + | |
Carbapenems | Piperacillin | + |
Doripenem | + | |
Ertapenem | + | |
Imipenem | + | |
Meropenem | + | |
Aztreonam | 0 | |
Fluroquinolones | Ciprofloxacin | +/- |
Ofloxacin | +/- | |
Pefloxacin | 0 | |
Levofloxacin | + | |
Moxifloxacin | + | |
Gemifloxacin | + | |
Gatifloxacin | + | |
1st G Cephalo | Cefazolin | + |
2nd G. Ceph | Cefotetan | + |
Cefoxitin | + | |
Cefuroxime | + | |
3rd/4th G. Ceph | Cefotaxime | + |
Cefizoxime | + | |
CefTRIAXone | + | |
Ceftobiprole | + | |
Ceftaroline | + | |
CefTAZidime | + | |
Cefepime | + | |
1st G. Ceph | Cefadroxil | + |
Cephalexin | + | |
2nd G. Ceph | Cefaclor/Loracarbef | + |
Cefproxil | + | |
Cefuroxime axetil | + | |
3rd G. Ceph | Cefixime | + |
Ceftibuten | + | |
Cefpodox/Cefdinir/Cefditoren | + | |
Aminoglycosides | Gentamicin | 0 |
Tobramycin | 0 | |
Amikacin | 0 | |
Chloramphenicol | + | |
Clindamycin | + | |
Macrolides | Erythromycin | +/- |
Azithromycin | +/- | |
Clarithromycin | +/- | |
Ketolide | Telithromycin | + |
Tetracyclines | Doxycycline | +/- |
Minocycline | + | |
Glycylcycline | Tigecycline | + |
Glyco/Lipoclycopeptides | Vancomycin | + |
Teicoplanin | + | |
Telavancin | + | |
Fusidic Acid | +/- | |
Trimethoprim | + | |
TMP-SMX | + | |
Urinary Agents | Nitrofurantoin | + |
Fosfomycin | ||
Other | Rifampin | + |
Metronidazole | 0 | |
Quinupristin dalfoppristin | + | |
Linezolid | + | |
Daptomycin | + | |
Colistimethate | 0 |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
|
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2010